Sharma, N., & Zirlik, A. (2015). Identification of resistance mechanism to targeting of the ADAM 17/ EGFR axis in triple negative breast cancer in vivo. Facultad de Farmacia y Bioquímica.
Cita Chicago Style (17a ed.)Sharma, Neha, y Andreas Zirlik. Identification of Resistance Mechanism to Targeting of the ADAM 17/ EGFR Axis in Triple Negative Breast Cancer in Vivo. Facultad de Farmacia y Bioquímica, 2015.
Cita MLA (8a ed.)Sharma, Neha, y Andreas Zirlik. Identification of Resistance Mechanism to Targeting of the ADAM 17/ EGFR Axis in Triple Negative Breast Cancer in Vivo. Facultad de Farmacia y Bioquímica, 2015.
Precaución: Estas citas no son 100% exactas.